Efficacy of propafenone in paramyotonia congenita

Neurology

Volumn 68, Issue 13, 2007, Pages 1080-1081

  Alfonsi, E ^a   Merlo, I M ^a   Tonini, M ^b   Ravaglia, S ^a   Brugnoni, R ^c   Gozzini, A ^a   Moglia, A ^a  

^a C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MEXILETINE; PROPAFENONE; SODIUM CHANNEL;

ADULT; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CONFUSION; CONSTIPATION; CONTROLLED STUDY; DEPOLARIZATION; DRUG BINDING; DRUG EFFICACY; DRUG WITHDRAWAL; ELECTRODIAGNOSIS; ELECTROMYOGRAPHY; ELECTROPHYSIOLOGY; EXERCISE TEST; GENE MUTATION; HUMAN; HYPOTHESIS; INFORMED CONSENT; MALE; MEMBRANE STEADY POTENTIAL; MULTIPLE CYCLE TREATMENT; MUSCLE ACTION POTENTIAL; MUSCLE STIFFNESS; MYOTONIA; NAUSEA; PARALYSIS; PRIORITY JOURNAL; RATING SCALE; SARCOLEMMA; SKELETAL MUSCLE; SYMPTOMATOLOGY; THOMSEN DISEASE; VOMITING;

ACTION POTENTIALS; ADULT; ANTI-ARRHYTHMIA AGENTS; DNA MUTATIONAL ANALYSIS; DRUG ADMINISTRATION SCHEDULE; GENETIC MARKERS; GENETIC SCREENING; HUMANS; MALE; MUSCLE HYPERTONIA; MUSCLE, SKELETAL; MUTATION; MYOTONIC DISORDERS; PARALYSIS; PROPAFENONE; SODIUM CHANNEL BLOCKERS; SODIUM CHANNELS; TREATMENT OUTCOME;

EID: 34147179031     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000257825.29703.e8     Document Type: Article

References (7)

1. Ptacek LJ, George AL Jr, Barchi RL, et al. Mutation in an S4 segment of the adult skeletal muscle sodium channel cause paramyotonia congenita. Neuron 1992;8:891-897.
2. Cannon SC. Myotonia and periodic paralysis: disorders of voltage-gated ion channels. In: Noseworthy JH, ed. Neurological therapeutics: principles and practice. London: Martin Dunitz, 2003:2365-2377.
3. Harron DW, Brogden RN. Propafenone: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias. Drugs 1987;34:617-647.
4. Wang S-Y, Moczydlowski, Wang GK. Inactivation-deficient human skeletal muscle Na+ channels (hNav1.4-L443C/A444W) in stably transfected HEK-293 cells. Receptors Channels 2004;10:131-138.
5. Mathieu J, De Braekeleer M, Prévost C, Boily C. Myotonic dystrophy: clinical assessment of muscular disability in an isolated population with presumed homogeneous mutation. Neurology 1992;42:203-208.
6. Streib EW, Sun SF, Yarkowski T. Transient paresis in myotonic syndromes: a simplified electrophysiological approach. Muscle Nerve 1982;5:719-723.
7. Vicart S, Sternberg D, Fontaine B, Meola G. Human skeletal muscle sodium channel channelopathies. Neurol Sci 2005;26:194-202.